investorscraft@gmail.com

Intrinsic Valueexceet Group SCA (EXC.DE)

Previous Close5.65
Intrinsic Value
Upside potential
Previous Close
5.65

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

exceet Group SCA operates as a shell company with no significant active operations, focusing instead on an opportunistic investment approach without a defined strategy. Historically, it provided products and solutions for healthcare and industrial markets, but its current structure under subsidiary White Elephant S.à r.l. suggests a shift toward passive asset management. The company’s lack of a clear investment mandate or sector specialization places it in a niche segment of financial services, distinct from traditional holding firms or private equity vehicles. Its market positioning is ambiguous, given the absence of a structured business model or revenue-generating activities, making it difficult to assess competitive advantages or industry relevance. The Luxembourg-based entity remains a speculative holding vehicle with minimal operational footprint, appealing primarily to investors seeking exposure to potential future asset acquisitions or restructuring.

Revenue Profitability And Efficiency

In FY 2022, exceet reported negligible revenue of €3.8 million, alongside a net loss of €3.9 million, reflecting its inactive operational status. The negative operating cash flow of €4.1 million further underscores the absence of sustainable income streams. With minimal capital expenditures, the company’s financials suggest a dormant state, reliant on existing liquidity rather than productive investments.

Earnings Power And Capital Efficiency

The company’s diluted EPS of -€0.19 and lack of operating income highlight its inability to generate earnings. Capital efficiency is virtually nonexistent, as exceet’s cash reserves of €117.4 million remain largely unutilized, with no discernible return on deployed capital or strategic reinvestment activity.

Balance Sheet And Financial Health

exceet maintains a robust liquidity position with €117.4 million in cash and equivalents, against negligible debt of €9,000. This conservative balance sheet structure provides flexibility but also indicates underutilization of financial resources. The absence of leverage suggests low financial risk, though the idle capital raises questions about long-term value creation.

Growth Trends And Dividend Policy

No growth trends are observable, given the company’s non-operational status. exceet has not paid dividends, aligning with its focus on preserving cash for speculative investments. Shareholder returns are contingent on future strategic shifts or asset monetization, neither of which are currently evident.

Valuation And Market Expectations

The market capitalization of €205 million appears disconnected from fundamentals, likely reflecting speculative expectations around potential future deals. The low beta of 0.22 implies minimal correlation with broader market movements, consistent with its shell company profile.

Strategic Advantages And Outlook

exceet’s sole advantage lies in its liquidity, which could facilitate opportunistic acquisitions. However, without a clear strategy or management track record, the outlook remains uncertain. Investors must weigh the potential for future activity against the current lack of direction.

Sources

Company filings, market data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount